Shizuoka, Japan

Shiori Kariyuki

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 21.0

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shiori Kariyuki: Innovator in Peptide Compound Cyclization

Introduction

Shiori Kariyuki is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of drug discovery through his innovative methods for cyclizing peptide compounds. With a total of 3 patents to his name, Kariyuki is recognized for his dedication to advancing pharmaceutical research.

Latest Patents

One of his latest patents is a peptide-compound cyclization method. The objective of this invention is to provide methods for discovering drugs that are effective for tough targets, which have traditionally been challenging to identify. This invention relates to novel methods for cyclizing peptide compounds, as well as novel peptide compounds and libraries that comprise these compounds, aimed at achieving the aforementioned objective.

Career Highlights

Kariyuki has established himself as a key figure in the pharmaceutical industry. His work has been instrumental in developing new approaches to drug discovery, particularly in the area of peptide compounds. His innovative techniques have the potential to revolutionize how researchers approach difficult drug targets.

Collaborations

Throughout his career, Shiori Kariyuki has collaborated with talented individuals such as Takeo Iida and Miki Kojima. These collaborations have further enhanced his research and contributed to the success of his projects.

Conclusion

In summary, Shiori Kariyuki is a pioneering inventor whose work in peptide compound cyclization is paving the way for new drug discovery methods. His contributions are vital to the advancement of pharmaceutical research and hold promise for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…